Lupin Limited
LUPIN
Classificação em ações
#2148
Lupin Limited is a pharmaceutical firm dedicated to the creation,... Lupin Limited is a pharmaceutical firm dedicated to the creation, manufacturing, commercialization, and distribution of a wide array of branded and generic medications, biotechnology items, and active pharmaceutical ingredients (APIs). Its comprehensive product portfolio addresses diverse therapeutic categories, including cardiovascular health, diabetes management, asthma, pediatric care, central nervous system disorders, gastrointestinal issues, anti-infectives, nonsteroidal anti-inflammatory drug (NSAID) therapy, respiratory ailments, women's health, and anti-tuberculosis treatments. Beyond its primary offerings, Lupin also supplies biosimilars and over-the-counter (OTC) medicines, alongside specialized pharmaceutical products. The company actively pursues drug discovery and development initiatives focused on oncology, immunology, and metabolic disorders, complementing these efforts with bio-clinical research. Lupin Limited maintains an extensive operational network comprising 18 laboratories, 280 LupiMitra collection centers, and 450 pick-up points. Its global presence extends across numerous countries, such as India, the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. Originally named Lupin Chemicals Limited, the company adopted its current identity, Lupin Limited, in 2001 following its merger with Lupin Laboratories Limited. Established in 1968, Lupin Limited is based in Mumbai, India.
Preço da ação
$20.35
Valor de mercado
$9.30B
Variação (1 dia)
-5.06%
Variação (1 ano)
-7.79%
País
IN
Negociar Lupin Limited (LUPIN)
Categoria
Healthcare
Histórico de preços das ações de Lupin Limited (LUPIN)
Preço de fecho mais alto: $21.67 em 2026-10-01
Preço de fecho mais baixo: $0.15 em 2001-09-01
Preço de fecho mais baixo: $0.15 em 2001-09-01
Histórico de preços das ações da Lupin Limited de 2001 a 2026
Desempenho anual do preço das ações
| Ano | Desempenho |
|---|---|
| 2026 (TTM) | 4.87% |
| 2025 | -7.64% |
| 2024 | 65.92% |
| 2023 | 66.87% |
| 2022 | -23.57% |
| 2021 | -7.86% |
| 2020 | 20.18% |
| 2019 | -9.99% |
| 2018 | -9.76% |
| 2017 | -39.41% |
| 2016 | -19.49% |
| 2015 | 18.35% |
| 2014 | 59.89% |
| 2013 | 29.56% |
| 2012 | 32.51% |
| 2011 | -19.07% |
| 2010 | 66.57% |
| 2009 | 159.72% |
| 2008 | -20.92% |
| 2007 | 17.92% |
| 2006 | 53.29% |
| 2005 | 5.97% |
| 2004 | -2.10% |
| 2003 | 510.86% |
| 2002 | 19.06% |
| 2001 | 0.00% |
Preço das ações de empresas similares ou concorrentes
| Empresa | Preço da ação | Variação 1a% | País |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
